TerminatedPhase 1NCT03579888

CD19-Specific T Cells Post AlloSCT

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
M.D. Anderson Cancer Center
Principal Investigator
Partow Kebriaei
M.D. Anderson Cancer Center
Intervention
Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T Cells(biological)
Enrollment
4 enrolled
Eligibility
18-70 years · All sexes
Timeline
20202021

Study locations (1)

Collaborators

Ziopharm Oncology

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03579888 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials